Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver

Biotechnology and Bioengineering

Volumn 109, Issue 12, 2012, Pages 3182-3188

  Nibourg, Geert A A ^a   Boer, Justin D ^a   van der Hoeven, Tessa V ^a   Ackermans, Mariëtte T ^a   van Gulik, Thomas M ^a   Chamuleau, Robert A F M ^a   Hoekstra, Ruurdtje ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Bioartificial liver; Flow rate; HepaRG; Perfusion

Indexed keywords

ACCURATE MEASUREMENT; BIOARTIFICIAL LIVER; CELL DAMAGE; HEPARG; HEPATIC FUNCTION; HIGH-FLOW RATE; LIVER CELLS; MASS BALANCE; OPTIMAL FLOWS; PERFUSION; PERFUSION RATE; UREA PRODUCTION;

AMMONIA; ARTIFICIAL ORGANS; BIOCONVERSION; BIOREACTORS; CELL CULTURE; CELLS; SUBSTRATES; UREA;

FLOW RATE;

AMMONIA; LACTIC ACID; TESTOSTERONE; UREA;

ARTICLE; ARTIFICIAL LIVER; BIOARTIFICIAL LIVER; BIOREACTOR; FLOW RATE; HUMAN; LIVER CELL; LIVER CELL CULTURE; LIVER FAILURE; LIVER FUNCTION; LIVER PERFUSION;

AMMONIA; BIOMEDICAL ENGINEERING; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL LINE; HEPATOCYTES; HUMANS; LACTIC ACID; LIVER, ARTIFICIAL; PERFUSION;

EID: 84868137838     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24586     Document Type: Article

References (25)

1. Abrahamse SL, van de Kerkhove MP, Sosef MN, Hartman R, Chamuleau RA, van Gulik TM. 2002. Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system. Int J Artif Organs 25:966-974;.
2. Butterworth RF. 2003. Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: Potential for improvement following their removal by liver assist devices. Liver Int 23(Suppl 3):5-9;.
3. Carpentier B, Gautier A, Legallais C. 2009. Artificial and bioartificial liver devices: Present and future. Gut 58:1690-1702;.
4. Catapano G, De Bartolo L. 1996. Importance of the kinetic characterization of liver cell metabolic reactions to the design of hybrid liver support devices. Int J Artif Organs 19:670-676;.
5. Catapano G, De Bartolo L. 1998. Technique for the kinetic characterization of the metabolic reactions of hepatocytes in adhesion culture. Biotechnol Prog 14:500-507;.
6. Chamuleau RA, Poyck PP, van de Kerkhove MP. 2006. Bioartificial liver: Its pros and cons. Ther Apher Dial 10:168-174;.
7. Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. 2004. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239:660-667;.
8. Flendrig LM, la Soe JW, Jorning GG, Steenbeek A, Karlsen OT, Bovee WM, Ladiges NC, Te Velde A., Chamuleau RA. 1997. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 26:1379-1392;.
9. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99:15655-15660;.
10. Hoekstra R, Nibourg GA, van der Hoeven TV, Ackermans MT, Hakvoort TB, van Gulik TM, Lamers WH, Oude Elferink RPJ, Chamuleau RAFM. 2011. The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol 43:1483-1489;.
11. Huizenga JR, Tangerman A, Gips CH. 1992. A rapid method for blood ammonia determination using the new blood ammonia checker (BAC) II. Clin Chim Acta 210:153-155;.
12. Iwata H, Park YG, Ikada Y. 1998. Importance of the extracorporeal circulation rate in a bioartificial liver. Mat Sci Eng C 6:235-243;.
13. Miyoshi H, Ehashi T, Kawai H, Ohshima N, Suzuki S. 2010. Three-dimensional perfusion cultures of mouse and pig fetal liver cells in a packed-bed reactor: Effect of medium flow rate on cell numbers and hepatic functions. J Biotechnol 148:226-232;.
14. Newsome PN, Tsiaoussis J, Masson S, Buttery R, Livingston C, Ansell I, Ross JA, Sethi T, Hayes PC, Plevris JN. 2004. Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology 40:636-645;.
15. Nibourg GA, Chamuleau RA, van der Hoeven TV, Maas MA, Ruiter AF, Lamers WH, Oude Elferink RPJ, van Gulik TM, Hoekstra R. 2012. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure. PlosOne 7:e38778.
16. Nibourg GA, Huisman MT, van der Hoeven TV, van Gulik TM, Chamuleau RA, Hoekstra R. 2010. Stable overexpression of Pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application. Liver Transpl 16:1075-1085;.
17. Park YG, Son YS, Ryu HW. 2003. Perifusion model for detoxification of drugs in a bioartificial liver. Int J Artif Organs 26:383-394;.
18. Paul R, Apel J, Klaus S, Schugner F, Schwindke P, Reul H. 2003. Shear stress related blood damage in laminar couette flow. Artif Organs 27:517-529;.
19. Poyck PP, Mareels G, Hoekstra R, van Wijk AC, van der Hoeven TV, van Gulik TM, Verdonck PR, Chamuleau RAFM. 2008. Enhanced oxygen availability improves liver-specific functions of the AMC bioartificial liver. Artif Organs 32:116-126;.
20. Reis VM, Guidetti L, Duarte JA, Ascensao A, Silva AJ, Sampaio JE, Russell AP, Baldari C. 2007. Slow component of VO(2) during level and uphill treadmill running: Relationship to aerobic fitness in endurance runners. J Sports Med Phys Fitness 47:135-140;.
21. Rose C, Ytrebo LM, Davies NA, Sen S, Nedredal GI, Belanger M, Revhaug A, Jalan R, 2007. Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. Hepatology 46:1883-1892;.
22. Roy P, Washizu J, Tilles AW, Yarmush ML, Toner M. 2001. Effect of flow on the detoxification function of rat hepatocytes in a bioartificial liver reactor. Cell Transplant 10:609-614;.
23. Tilles AW, Baskaran H, Roy P, Yarmush ML, Toner M. 2001. Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng 73:379-389;.
24. van de Kerkhove MP, Poyck PP, Deurholt T, Hoekstra R, Chamuleau RA, van Gulik TM. 2005a. Liver support therapy: An overview of the AMC-bioartificial liver research. Dig Surg 22:254-264;.
25. van de Kerkhove MP, Poyck PP, van Wijk AC, Galavotti D, Hoekstra R, van Gulik TM, Chamuleau RAFM. 2005b. Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs 28:617-630;.